Wize Pharma‘s LO2A eye drops result in clinically meaningful improvements in dry eye signs and symptoms in people with…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
The National Institute of Arthritis and Musculoskeletal and Skin Diseases, a part of the National Institutes of Health, has…
People with primary Sjögren’s syndrome have poor overall and oral health-related quality of life compared to healthy people,…
A Phase 4 clinical trial investigating LO2A eye drops, by Wize Pharma, as a treatment for dry eye symptoms in…
Non-invasive Test May Help Diagnose Peripheral Nerve Damage in Sjögren’s Patients, Study Suggests
A non-invasive test that measures nerve conduction through surface electrodes may help diagnose polyneuropathy — damage to…
Doctors should suspect primary Sjögren’s syndrome when examining patients, especially young women, with recurrent aseptic meningitis — a form of…
American Indians are more commonly affected by Sjögren’s syndrome and show more active disease compared to Americans of other…
Advanz Pharma has acquired the global rights (except in Japan) to market Salagen (pilocarpine hydrochloride) tablets, an approved therapy…
The Hungarian regulatory authority has agreed to extend the label of Wize Pharma‘s LO2A eye drops to include the treatment of…
Lower levels of Gαq — a protein that regulates many aspects of immune responses — appear to drive the progression of…